Acción 8037 CHINA BIOTECH SERVICES HOLDINGS LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas China Biotech Services Holdings Limited

Acciones

8037

BMG2152F1014

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:08:42 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,4 HKD +19,40 % Gráfico intradía de China Biotech Services Holdings Limited +1,27 % -48,05 %
13/06 China Biotech Services Holdings Limited anuncia la dimisión de Chui Hoi Yam como directora no ejecutiva CI
06/06 China Biotech Services Holdings Limited elige a Guo Yuantao como director no ejecutivo independiente CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
China Biotech Services Holdings Limited Announces Resignation of Chui Hoi Yam as Non-Executive Director
China Biotech Services Holdings Limited Elects Guo Yuantao as an Independent Non-Executive Director
China Biotech Services Holdings Limited Announces the Results of the Phase I Clinical Study of LY007 Cellular Injection
China Biotech Services Holdings Limited Announces Retirement of Ho Ivan Chun Kit as Independent Non-Executive Director
China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Biotech Services Holdings Limited announced that it expects to receive HKD 88 million in funding
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 8037
  4. Noticias China Biotech Services Holdings Limited
  5. Otros idiomas